Literature DB >> 20821293

The metabolic switch and its regulation in cancer cells.

ShengTao Zhou1, CanHua Huang, YuQuan Wei.   

Abstract

The primary features of cancer are maintained via intrinsically modified metabolic activity, which is characterized by enhanced nutrient supply, energy production, and biosynthetic activity to synthesize a variety of macromolecular components during each passage through the cell cycle. This metabolic shift in transformed cells, as compared with non-proliferating cells, involves aberrant activation of aerobic glycolysis, de novo lipid biosynthesis and glutamine-dependent anaplerosis to fuel robust cell growth and proliferation. Here, we discuss the unique metabolic characteristics of cancer, the constitutive regulation of metabolism through a variety of signal transduction pathways and/or enzymes involved in metabolic reprogramming in cancer cells, and their implications in cancer diagnosis and therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20821293     DOI: 10.1007/s11427-010-4041-1

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  8 in total

1.  Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.

Authors:  Cristina Di Poto; Alessia Ferrarini; Yi Zhao; Rency S Varghese; Chao Tu; Yiming Zuo; Minkun Wang; Mohammad R Nezami Ranjbar; Yue Luo; Chi Zhang; Chirag S Desai; Kirti Shetty; Mahlet G Tadesse; Habtom W Ressom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-02       Impact factor: 4.254

2.  5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN.

Authors:  Vlasta Demeckova; Dagmar Mudronova; Sona Gancarcikova; Peter Kubatka; Karol Kajo; Monika Kassayova; Bianka Bojkova; Marian Adamkov; Peter Solár
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

Review 3.  Reprogramming of Fatty Acid Metabolism in Gynaecological Cancers: Is There a Role for Oestradiol?

Authors:  Azilleo Kristo Mozihim; Ivy Chung; Nur Akmarina B M Said; Amira Hajirah Abd Jamil
Journal:  Metabolites       Date:  2022-04-14

Review 4.  Cancer Metabolism and Drug Resistance.

Authors:  Mahbuba Rahman; Mohammad Rubayet Hasan
Journal:  Metabolites       Date:  2015-09-30

5.  Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.

Authors:  Claudio Pulito; Federica Mori; Andrea Sacconi; Frauke Goeman; Maria Ferraiuolo; Patrizia Pasanisi; Carlo Campagnoli; Franco Berrino; Maurizio Fanciulli; Rebecca J Ford; Massimo Levrero; Natalia Pediconi; Ludovica Ciuffreda; Michele Milella; Gregory R Steinberg; Mario Cioce; Paola Muti; Sabrina Strano; Giovanni Blandino
Journal:  Cell Discov       Date:  2017-07-04       Impact factor: 10.849

6.  Metabolic Reprogramming, Questioning, and Implications for Cancer.

Authors:  Pierre Jacquet; Angélique Stéphanou
Journal:  Biology (Basel)       Date:  2021-02-07

7.  Thioredoxin 1 supports colorectal cancer cell survival and promotes migration and invasion under glucose deprivation through interaction with G6PD.

Authors:  Fengying Lu; Daoquan Fang; Shuhan Li; Zuyue Zhong; Xiujiao Jiang; Qinqin Qi; Yining Liu; Wenqi Zhang; Xiaohui Xu; Yangyang Liu; Weijian Zhu; Lei Jiang
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

Review 8.  Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases.

Authors:  Akram Safaei; Afsaneh Arefi Oskouie; Seyed Reza Mohebbi; Mostafa Rezaei-Tavirani; Mohammad Mahboubi; Maryam Peyvandi; Farshad Okhovatian; Mona Zamanian-Azodi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.